Skip to main content
Scott Solomon, MD, Hematology, Atlanta, GA

ScottRobertSolomonMD

Hematology Atlanta, GA

Myeloproliferative Disorder Hematology-Oncology

Physician

Dr. Solomon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Solomon's full profile

Already have an account?

  • Office

    5670 Peachtree Dunwoody Rd
    Ste 1000
    Atlanta, GA 30342
    Phone+1 404-255-1930
    Fax+1 404-459-8510

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1998 - 2001
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1995 - 1998
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1997 - Present
  • GA State Medical License
    GA State Medical License 2005 - 2025
  • MD State Medical License
    MD State Medical License 2000 - 2005
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Graft Versus Host Disease (GVHD) after HLA-Mismatched Haploidentical Transplantation with Post-Transplant Cyclophosphamide Compared to Matched Unrelated Donor: Inciden...
    Scott R. Solomon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • SEL120 _ a First-in-Class CDK8/19 Inhibitor As a Novel Option for the Treatment of Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome - Data from Preclinica...
    Scott R. Solomon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Improved Survival in Patients Who Undergo Relapse of Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation
    Scott R. Solomon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Ixazomib Maintenance to Prevent Alloreactivity and Provide Anti-Malignancy Effects Following Nonmyeloablative T-Replete Haploidentical Peripheral Blood Stem Cell Trans... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • First in Human Study of SEL24/MEN1703, First in Class, Orally Available Dual PIM/FLT3 Kinase Inhibitor, in Patients with Acute Myeloid Leukemia 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Professional Memberships